Literature DB >> 27353012

Approach To Deliver Two Antioxidant Enzymes with Mesoporous Silica Nanoparticles into Cells.

Yu-Hsuan Lin1, Yi-Ping Chen, Tsang-Pai Liu2,3, Fan-Ching Chien4, Chih-Ming Chou, Chien-Tsu Chen, Chung-Yuan Mou1.   

Abstract

Reactive oxygen species (ROS) are important factors in many clinical diseases. However, direct delivery of antioxidant enzymes into cells is difficult due to poor cell uptake. A proper design of delivery of enzymes by nanoparticles is very desirable for therapeutic purposes. To overcome the cell barrier problem, a designed mesoporous silica nanoparticle (MSN) system with attached TAT-fusion denatured enzyme for enhancing cell membrane penetration has been developed. Simultaneous delivery of two up-downstream antioxidant enzymes, superoxide dismutase (SOD) and glutathione peroxidase(GPx), reveals synergistic efficiency of ROS scavenging, compared to single antioxidant enzyme delivery. TAT peptide conjugation provided a facile nonendocytosis cell uptake and escape from endosome while moving and aggregating along the cytoskeleton that would allow them to be close to each other at the same time, resulting in the cellular antioxidation cascade reaction. The two-enzyme delivery shows a significant synergistic effect for protecting cells against ROS-induced cell damage and cell cycle arrest. The nanocarrier strategy for enzyme delivery demonstrates that intracellular anti-ROS cascade reactions could be regulated by multifunctional MSNs carrying image fluorophore and relevant antioxidation enzymes.

Entities:  

Keywords:  antioxidant enzyme; cascade reaction; codelivery; glutathione peroxidase; mesoporous silica nanoparticle; reactive oxygen species; superoxide dismutase

Mesh:

Substances:

Year:  2016        PMID: 27353012     DOI: 10.1021/acsami.6b05834

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  9 in total

Review 1.  Reactive Oxygen Species-Regulating Strategies Based on Nanomaterials for Disease Treatment.

Authors:  Chenyang Zhang; Xin Wang; Jiangfeng Du; Zhanjun Gu; Yuliang Zhao
Journal:  Adv Sci (Weinh)       Date:  2020-12-20       Impact factor: 16.806

2.  Oral Administration of Therapeutic Enzyme Capsule for the Management of Inflammatory Bowel Disease.

Authors:  Xiao Liang; Kai Wen; Yingxuan Chen; Guangxu Fang; Shengcai Yang; Quanshun Li
Journal:  Int J Nanomedicine       Date:  2022-10-17

3.  Silica nanoparticles induce autophagy dysfunction via lysosomal impairment and inhibition of autophagosome degradation in hepatocytes.

Authors:  Ji Wang; Yongbo Yu; Ke Lu; Man Yang; Yang Li; Xianqing Zhou; Zhiwei Sun
Journal:  Int J Nanomedicine       Date:  2017-01-24

4.  Biotransporting Biocatalytic Reactors toward Therapeutic Nanofactories.

Authors:  Tomoki Nishimura; Kazunari Akiyoshi
Journal:  Adv Sci (Weinh)       Date:  2018-09-19       Impact factor: 16.806

Review 5.  Nanocomposites as biomolecules delivery agents in nanomedicine.

Authors:  Magdalena Bamburowicz-Klimkowska; Magdalena Poplawska; Ireneusz P Grudzinski
Journal:  J Nanobiotechnology       Date:  2019-04-03       Impact factor: 9.429

Review 6.  Protein Delivery into the Cell Cytosol using Non-Viral Nanocarriers.

Authors:  Yi-Wei Lee; David C Luther; Jessica A Kretzmann; Andrew Burden; Taewon Jeon; Shumei Zhai; Vincent M Rotello
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

7.  Polymer Micelles vs Polymer-Lipid Hybrid Vesicles: A Comparison Using RAW 264.7 Cells.

Authors:  Carina Ade; Xiaomin Qian; Edit Brodszkij; Paula De Dios Andres; Järvi Spanjers; Isabella N Westensee; Brigitte Städler
Journal:  Biomacromolecules       Date:  2022-01-12       Impact factor: 6.988

8.  Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood-Brain Barrier.

Authors:  Yi-Ping Chen; Chih-Ming Chou; Tsu-Yuan Chang; Hao Ting; Julien Dembélé; You-Tai Chu; Tsang-Pai Liu; Chun A Changou; Chien-Wei Liu; Chien-Tsu Chen
Journal:  Front Chem       Date:  2022-06-27       Impact factor: 5.545

Review 9.  Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules.

Authors:  Rafael R Castillo; Daniel Lozano; María Vallet-Regí
Journal:  Pharmaceutics       Date:  2020-05-07       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.